Analytical Data
-
Gene name
IGBP1
- Application
-
Alternative Names
IGBP1；IBP1；Immunoglobulin-binding Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P78318
-
Expression Region
2-339aa
-
AA Sequence
AAEDELQLP RLPELFETGR QLLDEVEVAT EPAGSRIVQE KVFKGLDLLE KAAEMLSQLD LFSRNEDLEE IASTDLKYLL VPAFQGALTM KQVNPSKRLD HLQRAREHFI NYLTQCHCYH VAEFELPKTM NNSAENHTAN SSMAYPSLVA MASQRQAKIQ RYKQKKELEH RLSAMKSAVE SGQADDERVR EYYLLHLQRW IDISLEEIES IDQEIKILRE RDSSREASTS NSSRQERPPV KPFILTRNMA QAKVFGAGYP SLPTMTVSDW YEQHRKYGAL PDQGIAKAAP EEFRKAAQQQ EEQEEKEEED DEQTLHRARE WDDWKDTHPR GYGNRQNMG
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IGBP1 (Immunoglobulin Binding Protein 1) is a membrane-associated protein that plays a crucial role in various cellular processes, including signal transduction, cell adhesion, and immune response modulation. Research on IGBP1 has gained significant attention due to its potential implications in pathophysiological conditions such as cancer, autoimmune diseases, and infectious diseases. The ability of IGBP1 to interact with immunoglobulins suggests it may influence the effectiveness of immune responses, making it a target for therapeutic interventions. Recent studies have focused on the recombinant expression of IGBP1 to facilitate its characterization, including its structure, function, and interactions with other proteins. By employing techniques such as molecular cloning and expression in heterologous systems, researchers aim to produce high yields of functional IGBP1. This research not only aids in understanding the biological significance of IGBP1 but also opens pathways for developing novel diagnostic and therapeutic strategies, potentially enhancing immune response or modulating inflammatory pathways. As the study of IGBP1 progresses, it holds promise for uncovering new insights into immune system regulation and its role in various diseases, thereby contributing to advancements in immunology and related fields.
